DLA Piper represented NuVasive, Inc. in connection with its acquisition of Ellipse Technologies, a medical technology company focused on revolutionizing procedural solutions for complex skeletal deformity. The deal was announced January 5, 2016, and consists of a US$380 million upfront cash payment and a potential $30 million milestone payable in 2017 related to the achievement of specific revenue targets.

The acquisition builds on NuVasive's reputation as the leading technology provider for spine procedure solutions by adding a highly regarded, disruptive technology platform. Ellipse's magnetic growing rod technology is receiving rapid adoption in the pediatric deformity and orthopedic markets, providing growth opportunities beyond NuVasive's current portfolio of solutions that address adult degenerative and deformity spinal conditions.

The transaction is expected to close by the end of February 2016, subject to customary closing conditions and regulatory approvals. After the closing, NuVasive plans to maintain a Design Center of Excellence in Aliso Viejo, California, where Ellipse is headquartered.

The DLA Piper team representing NuVasive was led by San Diego partners Mike Kagnoff and Larry Nishnick.